Epigenomics AG Statistics

Total Valuation

Epigenomics AG has a market cap or net worth of 886,214. The enterprise value is 12.89 million.

Market Cap	886,214
Enterprise Value	12.89M

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	880,000
Shares Outstanding	n/a
Shares Change (YoY)	+2.76%
Shares Change (QoQ)	+0.41%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.72
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.09

Current Ratio	2.09
Quick Ratio	1.99
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-5.72%
Return on Invested Capital (ROIC)	-6.08%
Return on Capital Employed (ROCE)	-9.93%
Revenue Per Employee	n/a
Profits Per Employee	-1.74M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.18% in the last 52 weeks. The beta is 1.08, so Epigenomics AG's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	+9.18%
50-Day Moving Average	0.68
200-Day Moving Average	1.91
Relative Strength Index (RSI)	49.73
Average Volume (20 Days)	2,068

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.17M
Pretax Income	-3.47M
Net Income	-3.47M
EBITDA	-1.16M
EBIT	-1.17M
Earnings Per Share (EPS)	-3.96

Full Income Statement

Balance Sheet

The company has 959,727 in cash and 11.78 million in debt, giving a net cash position of -10.82 million.

Cash & Cash Equivalents	959,727
Total Debt	11.78M
Net Cash	-10.82M
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	523,865

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.25M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Epigenomics AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.76%
Shareholder Yield	n/a
Earnings Yield	-391.59%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3